US OptionsDetailed Quotes
SLDB250117P15000
- 0.00
- 0.000.00%
15min DelayClose Jan 7 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest15.00Strike Price0.00Turnover765.28%IV-282.65%PremiumJan 17, 2025Expiry Date11.08Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.6655Delta0.0737Gamma0.34Leverage Ratio-0.0897Theta-0.0030Rho-0.22Eff Leverage0.0024Vega
Solid Biosciences Stock Discussion
Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich's Ataxia
Tuesday, 7th January at 4:15 pm
- SGT-212 is the only full-length frataxin replacement gene therapy candidate targeting the CNS and cardiac manifestations of Friedreich's ataxia -
- Dual route of administration enables direct delivery of AAV-based gene therapy to the cerebellum and...
RA capital and perspective advisors are both investors here. They also are invested in $Bright Minds Biosciences (DRUG.US)$
DRUG ran recently as we all know but also ran 3000% in 2022. Each time RA Capital and perspective advisors were invested and both times there were private placements after they ran.
In 2021 SLDB ran 450%, RA Capital and perspective advisors both invested and a private placement after it ran.
SLDB has not had a major run since but maybe it will a...
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...
Moomoo 24/7· 1 min ago
No comment yet